Dexamethasone inhibits interleukin-1β-induced corneal neovascularization: Role of nuclear factor-κB-activated stromal cells in inflammatory angiogenesis

American Journal of Pathology

Volumn 171, Issue 3, 2007, Pages 1058-1065

  Nakao, Shintaro ^a,b,d   Hata, Yasuaki ^a   Miura, Muneki ^a   Noda, Kousuke ^d   Kimura, Yusuke N ^a,c   Kawahara, Shuhei ^a   Kita, Takeshi ^a   Hisatomi, Toshio ^a,d   Nakazawa, Toru ^d   Jin, Yiping ^e   Dana, M Reza ^d,e   Kuwano, Michihiko ^a,c   Ono, Mayumi ^a,b   Ishibashi, Tatsuro ^a   Hafezi Moghadam, Ali ^d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^e SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DEXAMETHASONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CELL TYPE; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; DRUG INHIBITION; FIBROBLAST; IMPLANTATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STROMA CELL;

EID: 34548815246     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070172     Document Type: Article

References (42)

1. Folkman J, Ingber DE: Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 1987, 206:374-383
2. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ: Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985, 103:708-711
3. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DS, Folkman J: Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 1981, 78:1176-1180
4. Praia AD, Hirakata A, McInnes JS, Scroggs MW, Parikh I: The effect of angiostatic steroids and β-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. Exp Eye Res 1993, 57:693-698
5. Longenecker JP, Kilty LA, Johnson LK: Glucocorticoid influence on growth of vascular wall cells in culture. J Cell Physiol 1982, 113:197-202
6. West-Mays JA, Dwivedi DJ: The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol 2006, 38:1625-1631
7. Nakamura T, Ishikawa F, Sonoda KH, Hisatomi T, Qiao H, Yamada J, Fukata M, Ishibashi T, Harada M, Kinoshita S: Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci 2005, 46:497-503
8. Wilson SE, Mohan RR, Mohan RR, Ambrosio Jr R, Hong J, Lee J: The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001, 20:625-637
9. Fini ME, Stramer BM: How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea 2005, 24:S2-S11
10. Chang LK, Garcia-Cardena G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A: Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA 2004, 101:11658-11663
11. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147
12. Dana MR, Zhu SN, Yamada J: Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 1998, 17:403-409
13. BenEzra D, Hemo I, Maftzir G: In vivo angiogenic activity of interleukins. Arch Ophthalmol 1990, 108:573-576
14. Fukuda M, Mishima H, Otori T: Detection of interleukin-1β in the tear fluid of patients with corneal disease with or without conjunctival involvement. Jpn J Ophthalmol 1997, 41:63-66
15. Staats HF, Lausch RN: Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. J Immunol 1993, 151:277-283
16. Biswas PS, Banerjee K, Kim B, Rouse BT: Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol 2004, 172:3736-3744
17. Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT: Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J Virol 2005, 79:10589-10600
18. Kuwano T, Nakao S, Yamamoto H, Tsuneyoshi M, Yamamoto T, Kuwano M, Ono M: Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 2004, 18:300-310
19. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda KH, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, Ono M: Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1β-induced neovascularization and tumor growth. J Clin Invest 2005, 115:2979-2991
20. Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723
21. Saika S, Miyamoto T, Yamanaka O, Kato T, Ohnishi Y, Flanders KC, Ikeda K, Nakajima Y, Kao WW, Sato M, Muragaki Y, Ooshima A: Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-κB, in treatment of corneal alkali burns in mice. Am J Pathol 2005, 166:1393-1403
22. Lu Y, Fukuda K, Liu Y, Kumagai N, Nishida T: Dexamethasone inhibition of IL-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture. Invest Ophthalmol Vis Sci 2004, 45:2998-3004
23. Gendron RL, Liu CY, Paradis H, Adams LC, Kao WW: MK/T-1, an immortalized fibroblast cell line derived using cultures of mouse corneal stroma. Mol Vis 2001, 7:107-113
24. Ueda S, Basaki Y, Yoshie M, Ogawa K, Sakisaka S, Kuwano M, Ono M: PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib. Cancer Res 2006, 66:5346-5353
25. Loureiro RM, D'Amore PA: Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev 2005, 16:77-89
26. Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA: Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006, 42:768-778
27. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK: Acute cardiovascular protective effects of corticosteroids are mediated by non-transoriptional activation of endothelial nitric oxide synthase. Nat Med 2002, 8:473-479
28. Leibowitz HM, Kupferman A, Stewart RH, Kimbrough RL: Evaluation of dexamethasone acetate as a topical ophthalmic formulation. Am J Ophthalmol 1978, 86:418-423
29. Raizman M: Corticosteroid therapy of eye disease. Fifty years later. Arch Ophthalmol 1996, 114:1000-1001
30. Lu Y, Fukuda K, Nakamura Y, Kimura K, Kumagai N, Nishida T: Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts. Invest Ophthalmol Vis Sci 2005, 46:2346-2352
31. Olivier S, Robe P, Bours V: Can NF-κB be a target for novel and efficient anti-cancer agents? Biochem Pharmacol 2006, 72:1054-1068
32. Miller JW, Stinson WG, Folkman J: Regression of experimental iris neovascularization with systemic α-interferon. Ophthalmology 1993, 100:9-14
33. Manna SK, Mukhopadhyay A, Aggarwal BB: IFN-α suppresses activation of nuclear transcription factors NF-κB and activator protein 1 and potentiates TNF-induced apoptosis. J Immunol 2000, 165:4927-4934
34. + CXC chemokine-induced angiogenic activity. J Immunol 2000, 165:5269-5277
35. Yamagami S, Miyazaki D, Ono SJ, Dana MR: Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci 1999, 40:2892-2897
36. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348
37. Bourcier T, Berbar T, Paquet S, Rondeau N, Thomas F, Borderie V, Laroche L, Rostene W, Haour F, Lombet A: Characterization and functionality of CXCR4 chemokine receptor and SDF-1 in human corneal fibroblasts. Mol Vis 2003, 9:96-102
38. Wilson SE, Lloyd SA, He YG: Glucocorticoid receptor and interleukin-1 receptor messenger RNA expression in corneal cells. Cornea 1994, 13:4-8
39. Hong JW, Liu JJ, Lee JS, Mohan RR, Mohan RR, Woods DJ, He YG, Wilson SE: Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Invest Ophthalmol Vis Sci 2001, 42:2795-2803
40. Mueller MM, Fusenig NE: Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4:839-849
41. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999, 59:5002-5011
42. Saijo Y, Tanaka M, Miki M, Usui K, Suzuki T, Maemondo M, Hong X, Tazawa R, Kikuchi T, Matsushima K, Nukiwa T: Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol 2002, 169:469-475